ELIPULSE Trademark

Trademark Overview

On Monday, September 23, 2013, a trademark application was filed for ELIPULSE with the United States Patent and Trademark Office. The USPTO has given the ELIPULSE trademark a serial number of 86072457. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 21, 2025. This trademark is owned by Elixir Canada Medicine Company Ltd. The ELIPULSE trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Use in Commerce) (Based on 44(e)) Herbal supplements for medicinal purposes, specifically coronary heart disease
elipulse

General Information

Serial Number86072457
Word MarkELIPULSE
Filing DateMonday, September 23, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 21, 2025
Registration Number4581805
Registration DateTuesday, August 5, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements

Goods and Services(Based on Use in Commerce) (Based on 44(e)) Herbal supplements for medicinal purposes, specifically coronary heart disease
Translation of Words in MarkThe wording "Elipulse" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 21, 2025
Primary Code005
First Use Anywhere DateTuesday, May 13, 2014
First Use In Commerce DateWednesday, May 14, 2014

Trademark Owner History

Party NameElixir Canada Medicine Company Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVancouver V6M 2L
CA
Party NameElixir Canada Medicine Company Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver
CA
Party NameElixir Canada Medicine Company Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver
CA

Trademark Events

Event DateEvent Description
Thursday, January 2, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 26, 2013NEW APPLICATION ENTERED
Monday, September 30, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 2, 2014ASSIGNED TO EXAMINER
Thursday, January 2, 2014NON-FINAL ACTION WRITTEN
Thursday, January 2, 2014NON-FINAL ACTION E-MAILED
Wednesday, January 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 16, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 16, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 22, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 22, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, January 22, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 22, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, February 11, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 10, 2014ASSIGNED TO LIE
Wednesday, May 14, 2014TEAS STATEMENT OF USE RECEIVED
Monday, June 30, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 13, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 14, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 14, 2014USE AMENDMENT FILED
Tuesday, June 10, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, June 6, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 5, 2014REGISTERED-PRINCIPAL REGISTER
Monday, August 5, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 30, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 30, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, July 1, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 13, 2019TEAS SECTION 8 RECEIVED
Monday, September 30, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, August 5, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 21, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Monday, September 30, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED

Related Keywords

elipulse based coronary heart disease specifically medicinal commerce herbal supplements purposes